☰

Pierre Marc Bouloux - Publications

Affiliations: 
University College London, London, United Kingdom 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Boehm U, Bouloux PM, Dattani MT, de Roux N, Dodé C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nature Reviews. Endocrinology. 11: 547-64. PMID 26194704 DOI: 10.1038/Nrendo.2015.112  0.35
2015 Cariboni A, André V, Chauvet S, Cassatella D, Davidson K, Caramello A, Fantin A, Bouloux P, Mann F, Ruhrberg C. Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome. The Journal of Clinical Investigation. 125: 2413-28. PMID 25985275 DOI: 10.1172/Jci78448  0.313
2015 Tzoulis P, Bouloux PM. Inpatient hyponatraemia: adequacy of investigation and prevalence of endocrine causes. Clinical Medicine (London, England). 15: 20-4. PMID 25650193 DOI: 10.7861/clinmedicine.15-1-20  0.315
2012 Jayakody SA, Andoniadou CL, Gaston-Massuet C, Signore M, Cariboni A, Bouloux PM, Le Tissier P, Pevny LH, Dattani MT, Martinez-Barbera JP. SOX2 regulates the hypothalamic-pituitary axis at multiple levels. The Journal of Clinical Investigation. 122: 3635-46. PMID 22945632 DOI: 10.1172/Jci64311  0.31
2007 Kim S-, Hu Y, Cadman S, Bouloux P. Diversity in fibroblast growth factor receptor 1 regulation: Learning from the investigation of Kallmann syndrome Journal of Neuroendocrinology. 20: 141-163. PMID 18034870 DOI: 10.1111/J.1365-2826.2007.01627.X  0.313
2006 Pitteloud N, Meysing A, Quinton R, Acierno JS, Dwyer AA, Plummer L, Fliers E, Boepple P, Hayes F, Seminara S, Hughes VA, Ma J, Bouloux P, Mohammadi M, Crowley WF. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Molecular and Cellular Endocrinology. 254: 60-9. PMID 16764984 DOI: 10.1016/J.Mce.2006.04.021  0.325
2005 Turton JP, Mehta A, Raza J, Woods KS, Tiulpakov A, Cassar J, Chong K, Thomas PQ, Eunice M, Ammini AC, Bouloux PM, Starzyk J, Hindmarsh PC, Dattani MT. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clinical Endocrinology. 63: 10-8. PMID 15963055 DOI: 10.1111/j.1365-2265.2005.02291.x  0.321
2005 Bouloux P. Testim 1% testosterone gel for the treatment of male hypogonadism. Clinical Therapeutics. 27: 286-298. PMID 15878382 DOI: 10.1016/J.Dinthera.2005.02.015  0.308
2004 González-Martínez D, Hu Y, Bouloux PM. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome. Frontiers in Neuroendocrinology. 25: 108-30. PMID 15571757 DOI: 10.1016/j.yfrne.2004.06.001  0.302
2002 Bouloux P, Warne DW, Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism Fertility and Sterility. 77: 270-273. PMID 11821082 DOI: 10.1016/S0015-0282(01)02973-9  0.309
1994 Matfin G, Bouloux P. Hormone replacement in the hypopituitary patient. British Journal of Neurosurgery. 8: 403-407. PMID 7811403 DOI: 10.3109/02688699408995106  0.311
Show low-probability matches.